[1]
|
Means, R.T. (2016) Pure Red Cell Aplasia. Blood, 128, 2504-2509. https://doi.org/10.1182/blood-2016-05-717140
|
[2]
|
Da, Costa, L.M., Leblanc, T.M. and Narla, M. (2020) Dia-mond-Blackfan Anemia. Blood, 136, 1262-1273.
https://doi.org/10.1182/blood.2019000947
|
[3]
|
Willig, T.N., Niemeyer, C.M., et al. (1999) Identification of New Prognosis Factors from the Clinical and Epidemiologic Analysis of a Registry of 229 Diamond-Blackfan Anemia Pa-tients. Pediatric Research, 46, 553-561.
https://doi.org/10.1203/00006450-199911000-00011
|
[4]
|
Vlachos, A., Ball, S., et al. (2008) Diagnosing and Treating Diamond Blackfan Anaemia: Results of an International Clinical Consensus Conference. British Journal of Haematology, 142, 859-876.
https://doi.org/10.1111/j.1365-2141.2008.07269.x
|
[5]
|
Dessypris, E.N., Krantz, S.B., Roloff, J.S. and Lukens, J.N. (1982) Mode of Action of the IgG Inhibitor of Erythropoiesis in Transient Erythroblastopenia of Childhood. Blood, 59, 114-123.
https://doi.org/10.1182/blood.V59.1.114.114
|
[6]
|
Gagne, K.E., Ghazvinian, R., Yuan, D., et al. (2014) Pearson Marrow Pancreas Syndrome in Patients Suspected to Have Diamond-Blackfan Anemia. Blood, 124, 437-440. https://doi.org/10.1182/blood-2014-01-545830
|
[7]
|
Narla, A., Vlachos, A. and Nathan, D.G. (2011) Diamond Blackfan Anemia Treatment: Past, Present, and Future. Seminars in Hematology, 48, 117-123. https://doi.org/10.1053/j.seminhematol.2011.01.004
|
[8]
|
Ball, S.E., McGuckin, C.P., Jenkins, G. and Gor-don-Smith, E.C. (1996) Diamond-Blackfan Anaemia in the U.K.: Analysis of 80 Cases from a 20-Year Birth Cohort. British Journal of Haematology, 94, 645-653.
https://doi.org/10.1046/j.1365-2141.1996.d01-1839.x
|
[9]
|
Wang, H., Niu, H., Zhang, T., Xing, L., Shao, Z. and Fu, R. (2021) Low-and Intermediaterisk Myelodysplastic Syndrome with Pure Red Cell Aplasia. Hematology, 26, 444-446. https://doi.org/10.1080/16078454.2021.1929694
|
[10]
|
Hirokawa, M., Sawada, K., Fujishima, N., et al. (2015) Long-Term Outcome of Patients with Acquired Chronic Pure Red Cell Aplasia (PRCA) Following Immunosup-pressive Therapy: A Final Report of the Nationwide Cohort Study in 2004/2006 by the Japan PRCA Collaborative Study Group. British Journal of Haematology, 169, 879-886.
https://doi.org/10.1111/bjh.13376
|
[11]
|
Abkowitz, J.L., Kadin, M.E., Powell, J.S. and Adamson, J.W. (1986) Pure Red Cell Aplasia: Lymphocyte Inhibition of Erythropoiesis. British Journal of Haematology, 63, 59-67. https://doi.org/10.1111/j.1365-2141.1986.tb07495.x
|
[12]
|
Fujishima, N., Hirokawa, M., Fujishima, M., et al. (2006) Oligoclonal T Cell Expansion in Blood But Not in the Thymus from a Patient with Thymoma-Associated Pure Red Cell Aplasia. Haematologica, 91, ECR47.
|
[13]
|
Hirokawa, M., Sawada, K., Fujishima, N., et al. (2008) Long-Term Response and Outcome Following Immunosuppressive Therapy in Thymoma-Associated Pure Red Cell Aplasia: A Na-tionwide Cohort Study in Japan by the PRCA Collaborative Study Group. Haematologica, 93, 27-33. https://doi.org/10.3324/haematol.11655
|
[14]
|
Ishida, F., Matsuda, K., Sekiguchi, N., et al. (2014) STAT3 Gene Mutations and Their Association with Pure Red Cell Aplasia in Large Granular Lymphocyte Leukemia. Cancer Science, 105, 342-346. https://doi.org/10.1111/cas.12341
|
[15]
|
Frickhofen, N., Chen, Z.J., Young, N.S., Cohen, B.J., Heimpel, H. and Abkowitz, J.L. (1994) Parvovirus B19 as a Cause of Acquired Chronic Pure Red Cell Aplasia. British Journal of Haematology, 87, 818-824.
https://doi.org/10.1111/j.1365-2141.1994.tb06743.x
|
[16]
|
Tanaka, Y., Matsui, K., Yamashita, K., Matsuda, K., Shinohara, K. and Matsutani, A. (2006) T-Gamma Delta Large Granular Lymphocyte Leukemia Preceded by Pure Red Cell Aplasia and Complicated with Hemophagocytic Syndrome Caused by Epstein-Barr Virus Infection. Internal Medi-cine, 45, 631-635. https://doi.org/10.2169/internalmedicine.45.1594
|
[17]
|
Dessypris, E.N., Redline, S., Harris, J.W. and Krantz, S.B. (1985) Diphenylhydantoininduced Pure Red Cell Aplasia. Blood, 65, 789-794. https://doi.org/10.1182/blood.V65.4.789.789
|
[18]
|
Mariette, X., Mitjavila, M.T., Moulinie, J.P., et al. (1989) Ri-fampicin-Induced Pure Red Cell Aplasia. The American Journal of Medicine, 87, 459-460. https://doi.org/10.1016/S0002-9343(89)80833-2
|
[19]
|
Bennett, C.L., Luminari, S., Nissenson, A.R., et al. (2004) Pure Red-Cell Aplasia and Epoetin Therapy. The New England Journal of Medicine, 351, 1403-1408. https://doi.org/10.1056/NEJMoa040528
|
[20]
|
Choudry, M.A., Moffett, B.K. and Laber, D.A. (2007) Pure Red-Cell Aplasia Secondary to Pregnancy, Characterization of a Syndrome. Annals of Hematology, 86, 233-237. https://doi.org/10.1007/s00277-006-0211-4
|
[21]
|
Gurnari, C. and Maciejewski, J.P. (2021) How I Manage Ac-quired Pure Red Cell Aplasia in Adults. Blood, 137, 2001-2009.
https://doi.org/10.1182/blood.2021010898
|
[22]
|
Dessypris, E.N. (1988) Pure Red Cell Aplasia. Johns Hopkins University Press, Baltimore, 1-156.
|
[23]
|
Au, W.Y., Cheng, V.C., Wan, T.S. and Ma, S.K. (2004) Myelodysplasia Masquerading as Parvovirus-Related Red Cell Aplasia with Giant Pronormoblasts. Annals of Hematology, 83, 670-671. https://doi.org/10.1007/s00277-004-0894-3
|
[24]
|
Thompson, C.A. and Steensma, D.P. (2006) Pure Red Cell Apla-sia Associated with Thymoma: Clinical Insights from a 50-Year Single-Institution Experience. British Journal of Hae-matology, 135, 405-407.
https://doi.org/10.1111/j.1365-2141.2006.06295.x
|
[25]
|
Balasubramanian, S.K., Sadaps, M., Thota, S., et al. (2018) Rational Management Approach to Pure Red Cell Aplasia. Haematologica, 103, 221-230. https://doi.org/10.3324/haematol.2017.175810
|
[26]
|
Crabol, Y., Terrier, B., Rozenberg, F., et al. (2013) Intravenous Immunoglobulin Therapy for Pure Red Cell Aplasia Related to Human Parvovirus B19 Infection: A Retrospective Study of 10 Patients and Review of the Literature. Clinical Infectious Diseases, 56, 968-977. https://doi.org/10.1093/cid/cis1046
|
[27]
|
Wu, X., Yang, Y., Lu, X., et al. (2019) Induced Complete Remission Faster in Adult Patients with Acquired Pure Red Cell Aplasia by Combining Cyclosporine A with Corticosteroids. Medi-cine (Baltimore), 98, e17425.
https://doi.org/10.1097/MD.0000000000017425
|
[28]
|
D’Arena, G., Vigliotti, M.L., Dell’Olio, M., et al. (2009) Rituximab to Treat Chronic Lymphoproliferative Disorder-Associated Pure Red Cell Aplasia. European Journal of Haematology, 82, 235-239.
https://doi.org/10.1111/j.1600-0609.2008.01187.x
|
[29]
|
Au, W.Y., Lam, C.C., Chim, C.S., Pang, A.W. and Kwong, Y.L. (2005) Alemtuzumab Induced Complete Remission of Therapy-Resistant Pure Red Cell Aplasia. Leukemia Research, 29, 1213-1215.
https://doi.org/10.1016/j.leukres.2005.02.018
|
[30]
|
D’Arena, G. and Cascavilla, N. (2009) Chronic Lymphocytic Leukemia-Associated Pure Red Cell Aplasia. International Journal of Immunopathology and Pharmacology, 22, 279-286. https://doi.org/10.1177/039463200902200204
|
[31]
|
Elimelakh, M., Dayton, V., Park, K.S., et al. (2007) Red Cell Aplasia and Autoimmune Hemolytic Anemia Following Immunosuppression with Alemtuzumab, Mycopheno-late, and Daclizumab in Pancreas Transplant Recipients. Haematologica, 92, 1029-1036. https://doi.org/10.3324/haematol.10733
|
[32]
|
Zhang, L., Chen, N., Xu, Z., et al. (2021) Good Treatment-Free Sur-vival of Monoclonal Gammopathy of Undetermined Significance Associated Pure Red Cell Aplasia after Bortezomib plus Dexamethasone. Blood Cells, Molecules, and Diseases, 89, Article ID: 102573. https://doi.org/10.1016/j.bcmd.2021.102573
|
[33]
|
Halkes, C., De, Wreede, L.C., Knol, C., et al. (2019) Allogeneic Stem Cell Transplantation for Acquired Pure Red Cell Aplasia. American Journal of Hematology, 94, E294-E296. https://doi.org/10.1002/ajh.25609
|
[34]
|
Huang, Y., Chen, M., Yang, C., Ruan, J., Wang, S. and Han, B. (2022) Si-rolimus Is Effective for Refractory/Relapsed/ Intolerant Acquired Pure Red Cell Aplasia: Results of a Prospective Sin-gle-Institutional Trial. Leukemia, 36, 1351-1360.
https://doi.org/10.1038/s41375-022-01532-1
|
[35]
|
Chen, Z., Liu, X., Chen, M., Yang, C. and Han, B. (2020) Suc-cessful Sirolimus Treatment of Patients with Pure Red Cell Aplasia Complicated with Renal Insufficiency. Annals of Hematology, 99, 737-741.
https://doi.org/10.1007/s00277-020-03946-2
|
[36]
|
Worel, N. (2016) ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation. Transfusion Medicine and Hemotherapy, 43, 3-12. https://doi.org/10.1159/000441507
|
[37]
|
Aung, F.M., Lichtiger, B., Bassett, R., et al. (2013) Incidence and Natural History of Pure Red Cell Aplasia in Major ABO-Mismatched Haematopoietic Cell Transplantation. British Journal of Haematology, 160, 798-805.
https://doi.org/10.1111/bjh.12210
|
[38]
|
Martino, R., García-Cadenas, I. and Esquirol, A. (2022) Daratumumab May Be the Most Effective Treatment for Post-Engraftment Pure Red Cell Aplasia Due to Persistent Anti-Donor Isohemag-glutinins after Major ABO-Mismatched Allogeneic Transplantation. Bone Marrow Transplantation, 57, 282-285.
https://doi.org/10.1038/s41409-021-01507-3
|
[39]
|
Poon, L.M. and Koh, L.P. (2012) Successful Treatment of Iso-hemagglutinin-Mediated Pure Red Cell Aplasia after ABO-Mismatched Allogeneic Hematopoietic Cell Transplant Using Bortezomib. Bone Marrow Transplantation, 47, 870-871. https://doi.org/10.1038/bmt.2011.176
|
[40]
|
Means, R.T. (2022) Update on Pure Red Cell Aplasia: Etiology, Diagnosis, and Treatment. Clinical Advances in Hematology & On-cology, 20, 18-21.
|
[41]
|
Nakazawa, H., Sakai, K., Ohta, A., et al. (2022) Incidence of Acquired Pure Red Cell Aplasia: A Nationwide Epidemiologic Analysis with 2 Registry Databases in Japan. Blood Advances, 6, 6282-6290.
https://doi.org/10.1182/bloodadvances.2021006486
|